MYC and angiosarcoma: Reduced expression of thrombospondin-1 (THBS1) has been reported in MYC-amplified angiosarcomas (more on MYC amplifications in angiosarcomas below) [44], and its expression is either downregulated or lost across many cancers [45–48].